Neurology devices market seen reaching $35.94 billion by 2030

The Business Research Company says the global neurology devices market is on track to grow from $20.09 billion in 2025 to $35.94 billion by 2030, driven by rising neurological disease rates, new imaging tools and wider use of minimally invasive procedures. The report also points to North America as the largest market in 2025 and Asia-Pacific as the fastest-growing region.

Why it matters: - Neurology devices are becoming more important as demand rises for tools that diagnose, treat and prevent neurological conditions. - The market outlook suggests stronger investment in technologies tied to brain-computer interfaces, remote monitoring and precision neurology. - Faster adoption could expand access to treatment for disorders including Alzheimer’s disease, spinal cord injuries and traumatic brain injuries.

What happened: - The Business Research Company published its Neurology Devices Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 on August 19, 2026. - The report projects the neurology devices market will grow from $20.09 billion in 2025 to $22.44 billion in 2026. - The report forecasts the market will reach $35.94 billion by 2030. - The report says the market is advancing at an 11.7% CAGR historically and is expected to grow at a 12.5% CAGR through 2030.

The details: - Rising neurological disorder cases, more neurosurgical services in hospitals and wider access to advanced imaging are supporting current growth. - Demand for minimally invasive procedures and better clinical effectiveness is also fueling expansion. - The report points to greater investment in brain-computer interface research as a major driver of future growth. - Wider adoption of precision neurology, more outpatient neurology centers, non-invasive neurodiagnostic technologies and remote neurological monitoring are other projected growth factors. - Expected trend areas include neurostimulation therapies, image-guided neurosurgical systems, artificial intelligence in neurological diagnostics, minimally invasive procedures and personalized treatment. - The report says neurology devices are also used to restore sensory functions, including hearing and vision, for patients affected by limb loss or congenital limb anomalies. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The forecast suggests the market is moving from broad device expansion toward more specialized, software-enabled and outpatient-focused care. - FDA support for neurological and physical medicine devices through its Total Product Life Cycle Advisory Program points to a regulatory environment that may help speed device development. - The report’s emphasis on AI, remote monitoring and precision neurology signals a shift toward more data-driven treatment models. - North America held the largest market share in 2025, while Asia-Pacific is expected to be the fastest-growing region.

What's next: - The FDA planned to add four new offices to the TAP program by early 2025 and include up to 65 additional devices. - The market report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis.

The bottom line: - Neurology devices are moving into a faster-growth phase, with the biggest gains likely to come from advanced diagnostics, minimally invasive care and digital monitoring.